Laddar...
Institutional Experience of Using Andexanet Alfa
Given their ease of use, safety, and efficacy, direct-acting oral anticoagulants (DOACs) are nowadays widely used in patients with atrial fibrillation or venous thromboembolism, with or without an association with malignancy. Andexanet alfa (andexanet) is a recombinant modified human factor Xa decoy...
Sparad:
| I publikationen: | Cureus |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Cureus
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7425824/ https://ncbi.nlm.nih.gov/pubmed/32802609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9173 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|